Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali K Jaafar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Heart Journal|July 29, 2021
Heart to heart with PCSK9Kevin Chemello, Ali K Jaafar, Gilles Lambert
ACS Chemical Neuroscience|August 11, 2025
Divalent and Trivalent Metallic Ions Differentially Affect Alpha-Synuclein AggregationNoah J Graves, Ali K Jaafar, Yann Gambin, et al.
Current Opinion in Lipidology|February 28, 2026
Lipoprotein(a) in familial hypercholesterolemiaAli K Jaafar, Steeve Bourane, Gilles C Lambert, et al.
Journal of Lipid Research|August 16, 2023
PCSK9 and the nervous system: a no-brainer?Ali K Jaafar, Romuald Techer, Kévin Chemello, et al.
Journal of the American Heart Association|April 16, 2025
Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL TrialKévin Chemello, Alexis F Guedon, Romuald Techer, et al.
International Journal of Molecular Sciences|December 24, 2021
A Systematic Approach to Assess the Activity and Classification of PCSK9 VariantsKepa B Uribe, Kevin Chemello, Asier Larrea-Sebal, et al.
JCI Insight|May 8, 2025
PCSK9 deficiency promotes the development of peripheral neuropathyAli K Jaafar, Aurélie Paulo-Ramos, Guillaume Rastoldo, et al.
Journal of Lipid Research|October 9, 2022
A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In VivoAlexandra K Suchowerska, Geurt Stokman, James T Palmer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Heart Journal|July 29, 2021
Heart to heart with PCSK9Kevin Chemello, Ali K Jaafar, Gilles Lambert
ACS Chemical Neuroscience|August 11, 2025
Divalent and Trivalent Metallic Ions Differentially Affect Alpha-Synuclein AggregationNoah J Graves, Ali K Jaafar, Yann Gambin, et al.
Current Opinion in Lipidology|February 28, 2026
Lipoprotein(a) in familial hypercholesterolemiaAli K Jaafar, Steeve Bourane, Gilles C Lambert, et al.
Journal of Lipid Research|August 16, 2023
PCSK9 and the nervous system: a no-brainer?Ali K Jaafar, Romuald Techer, Kévin Chemello, et al.
Journal of the American Heart Association|April 16, 2025
Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL TrialKévin Chemello, Alexis F Guedon, Romuald Techer, et al.
International Journal of Molecular Sciences|December 24, 2021
A Systematic Approach to Assess the Activity and Classification of PCSK9 VariantsKepa B Uribe, Kevin Chemello, Asier Larrea-Sebal, et al.
JCI Insight|May 8, 2025
PCSK9 deficiency promotes the development of peripheral neuropathyAli K Jaafar, Aurélie Paulo-Ramos, Guillaume Rastoldo, et al.
Journal of Lipid Research|October 9, 2022
A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In VivoAlexandra K Suchowerska, Geurt Stokman, James T Palmer, et al.
Pageof 1